α-tocopherol and probucol reduce autoantibody titer to MDA-LDL in hypercholesterolemic rabbits

Free Radical Biology and Medicine

Volumn 31, Issue 6, 2001, Pages 778-789

  Schwenke, Dawn C ^a   Behr, Stephen R ^a,b  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b Les Laboratoires Æterna Inc 1405   (Canada)

Author keywords

Tocopherol; Antioxidant; Aorta; Atherosclerosis; Autoantibody; Cholesterol; Free radicals; Immunoglobulin; MDA LDL; Oxidized LDL; Probucol

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; AUTOANTIBODY; CHOLESTEROL; EPITOPE; IMMUNOGLOBULIN G; LOW DENSITY LIPOPROTEIN; PROBUCOL; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY TITER; AORTA ATHEROSCLEROSIS; ARTICLE; ATHEROGENESIS; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL DIET; CONTROLLED STUDY; DRUG BLOOD LEVEL; FEMALE; HUMORAL IMMUNITY; HYPERCHOLESTEROLEMIA; IMMUNOGLOBULIN BLOOD LEVEL; IN VIVO STUDY; NONHUMAN; OXIDATION; PRIORITY JOURNAL; RABBIT; TREATMENT OUTCOME; VITAMIN SUPPLEMENTATION;

ALPHA-TOCOPHEROL; ANIMALS; ANTICHOLESTEREMIC AGENTS; ANTIOXIDANTS; AORTA; ARTERIOSCLEROSIS; AUTOANTIBODIES; CHOLESTEROL; CHOLESTEROL, DIETARY; FEMALE; HYPERCHOLESTEROLEMIA; LIPOPROTEINS, LDL; MALONDIALDEHYDE; PROBUCOL; RABBITS;

ORYCTOLAGUS CUNICULUS;

EID: 0035884734     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(01)00645-1     Document Type: Article

References (80)

1. Antioxidants and atherogenesis
2. Is oxidized low-density lipoprotein present in vivo?
3. Immune responses to oxidative neoepitopes on LDL and phospholipids modulate the development of atherosclerosis
4. Low density lipoprotein undergoes oxidative modification in vivo
5. Antisera and monoclonal antibodies specific for epitopes generated during oxidative modification of low density lipoprotein
6. Distribution of oxidation specific lipid-protein adducts and apolipoprotein B in atherosclerotic lesions of varying severity from WHHL rabbits
7. Malondialdehyde-altered protein occurs in atheroma of Watanabe heritable hyperlipidemic rabbits
8. Oxidation-specific epitopes in human coronary atherosclerosis are not limited to oxidized low-density lipoprotein
9. Immunization with homologous oxidized low density lipoprotein reduces neointimal formation after balloon injury in hypercholesterolemic rabbits
10. Hyperimmunization of apo-E-deficient mice with homologous malondialdehyde low-density lipoprotein suppresses early atherogenesis
11. LDL immunization induces T-cell-dependent antibody formation and protection against atherosclerosis
12. Immunogenicity of homologous low density lipoprotein after methylation, ethylation, acetylation, or carbamylation: Generation of antibodies specific for derivatized lysine
13. Autoantibody against oxidised LDL and progression of carotid atherosclerosis
14. Autoantibodies against oxidatively-modified LDL in uremic patients undergoing dialysis
15. Autoantibodies against oxidatively modified low-density lipoproteins in NIDDM
16. Presence of autoantibodies against oxidatively modified low-density lipoprotein in essential hypertension: A biochemical signature of an enhanced in vivo low-density lipoprotein oxidation
17. Autoantibodies against malondialdehyde-modified LDL are elevated in subjects with an LDL subclass pattern B
18. Association of serum vitamin levels, LDL susceptibility to oxidation, and autoantibodies against MDA-LDL with carotid atherosclerosis - A case-control study
19. Effect of vitamin E on endothelial vasodilator function in patients with hypercholesterolemia, chronic smoking or both
20. Autoantibodies to markers of oxidative stress are elevated in women with endometriosis
21. Antibodies to oxidized lipoproteins and their relationship to myocardial infarction
22. Antioxidants, but not B-group vitamins increase the resistance of low-density lipoprotein to oxidation: A randomized, factorial design, placebo-controlled trial
23. Vitamin E supplementation in hyperlipidaemic patients: Effect of increasing doses on in vitro and in vivo low-density lipoprotein oxidation
24. Autoantibodies against oxidized low-density lipoprotein and cardiolipin in patients with coronary heart disease
25. Anti-oxidized LDL antibodies and antiphospholipid antibodies in healthy subjects: Relationship with lipoprotein- and oxidation-related analytes
26. Increased low density lipoprotein oxidation in stable kidney transplant recipients
27. Enhanced plasma level of lipid peroxidation in Iranians could be improved by antioxidants supplementation
28. Vitamin E supplementation decreases autoantibodies to oxidized lipid-protein complexes
29. Circulating autoantibodies recognizing peroxidase-oxidized low density lipoprotein - Evidence for new antigenic epitopes formed in vivo independently from lipid peroxidation
30. Autoantibody against oxidized low-density lipoprotein may be enhanced by cigarette smoking
31. Immunization of low density lipoprotein (LDL) receptor-deficient rabbits with homologous malondialdehyde-modified LDL reduces atherogenesis
32. Reciprocal changes in plasma vitamin E and autoantibody titer to malondialdehyde-low density lipoprotein
33. Vitamin E and probucol reduce autoantibody titer to low density lipoprotein modified by malondialdehyde
34. Dietary beta-carotene and alpha-tocopherol combination does not inhibit atherosclerosis in an ApoE-deficient mouse model
35. Circulating autoantibodies to oxidized LDL correlate with arterial accumulation and depletion of oxidized LDL in LDL receptor-deficient mice
36. Effect of vitamin E supplementation on antibody levels against malondialdehyde modified LDL in hyperlipidemic hamsters
37. Probucol inhibits oxidative modification of low density lipoprotein
38. Effect of antioxidants alone and in combination with monounsaturated fatty acid-enriched diets on lipoprotein oxidation
39. Vitamin E combined with selenium inhibits atherosclerosis in hypercholesterolemic rabbits independently of effects on plasma cholesterol concentrations
40. Immunochemical characterization of purified human oxidized low-density lipoprotein antibodies
41. Gender differences in intima-media permeability to low-density lipoprotein at atherosclerosis-prone aortic sites in rabbits: Lack of effect of 17beta-estradiol
42. Comparison of aorta and pulmonary artery. II. LDL transport and metabolism correlate with susceptibility to atherosclerosis
43. Malondialdehyde alteration of low density lipoproteins leads to cholesteryl ester accumulation in human monocyte-macrophages
44. ELISA of IgG antibody to oxidized low-density lipoprotein: Effects of blocking buffer and method of data expression
45. Effects of incubation conditions on ELISA for autoantibodies against oxidized low-density lipoprotein
46. Analysis and general classification of serum cryoglobulins by capillary zone electrophoresis
47. The microdissection of large atherosclerotic plaques to give morphologically and topographically defined fractions for analysis. Part 1. The lipids in the isolated fractions
48. Development of unesterified cholesterol-rich lipid particles in atherosclerotic lesions of WHHL and cholesterol-fed NZW rabbits
49. Nutritional control of arterial lipid composition in squirrel monkeys: Major ester classes and types of phospholipids
50. Vitamin E and the immune response
51. The role of vitamin-E in immunity during aging
52. Effect of vitamin E on atherogenesis in LDL receptor-deficient rabbits
53. Effects of green tea, black tea and dietary lipophilic antioxidants on LDL oxidizability and atherosclerosis in hypercholesterolaemic rabbits
54. Increased levels of autoantibodies to cardiolipin and oxidised low density lipoprotein are inversely associated with plasma vitamin C status in cigarette smokers
55. Increased oxidation of LDL in patients with coronary artery disease is independent from dietary vitamins E and C
56. Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: Evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atherosclerosis in the Watanabe heritable hyperlipidemic rabbit
57. Extent of antioxidant protection of plasma LDL is not a predictor of the antiatherogenic effect of antioxidants
58. A comparison of the antiatherogenic effects of probucol and of a structural analogue of probucol in low density lipoprotein receptor-deficient rabbits
59. Autoantibodies against oxidized low density lipoproteins (oxLDL): Characterization of antibody isotype, subclass, affinity and effect on the macrophage uptake of oxLDL
60. Antibodies against oxidized LDL and carotid artery intima-media thickness in a healthy population
61. Relationship between lipoprotein- and oxidation-related variables and atheroma lipid compostion in subjects undergoing coronary artery bypass graft surgery
62. Anti-oxidized low density lipoprotein antibody determination as a predictor of restenosis following percutaneous transluminal coronary angioplasty
63. Autoantibodies against oxidized low density lipoprotein in patients with angiographically verified coronary artery disease
64. Absence of relationship between plasma Lp(a), Lp-AI, anti-oxidized LDL autoantibodies, LDL immune complexes concentration and restenosis after percutaneous transluminal coronary angioplasty
65. Autoantibodies against oxidatively modified LDL do not constitute a risk factor for stroke: A nested case-control study
66. Mechanisms of high-density lipoprotein reduction after probucol treatment - Changes in plasma cholesterol esterification/transfer and lipase activities
67. Probucol increases cholesteryl ester transfer protein activity in hypercholesterolaemic patients
68. Combined effects of probucol and benzafibrate on lipoprotein metabolism and liver cholesteryl ester transfer protein mRNA in cholesterol-fed rabbits
69. Effects of vitamin E and HMG-CoA reductase inhibition on cholesteryl ester transfer protein and lecithin-cholesterol acyltransferase in hypercholesterolemia
70. Vitamin E supplementation increases resistance of both LDL and HDL to oxidation and increases cholesteryl ester transfer activity
71. Increase in plasma cholesteryl ester transfer protein during probucol treatment - Relation to changes in high density lipoprotein composition
72. High-density lipoproteins from probucol-treated patients have increased capacity to promote cholesterol efflux from mouse peritoneal macrophages loaded with acetylated low- density lipoproteins
73. The pecking order of free radicals and antioxidants-lipid peroxidation, alpha-tocopherol, and ascorbate
74. Feasibility of using an oleate-rich diet to reduce the susceptibility of low-density lipoprotein to oxidative modification in humans
75. Autoantibody titers to oxidized low-density lipoprotein in patients with coronary atherosclerosis
76. Autoantibodies against MDA-LDL in subjects with severe and minor atherosclerosis and healthy population controls